Patent · US Active

Insulin derivatives

US8828923B2 · kind B2 · utility

7Cited by
31References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2009
Grant dateSep 9, 2014
Priority date
Expiry dateSep 16, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P5/50
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the α-amino group of the N-terminal amino acid residue of the B chain or to the ε-amino group of a Lys residue present in the B chain of the parent insulin, the side chain being of the general formula:—W—X—Y—Zwherein W, X, Y and Z are as defined in the disclosure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.